ARCHIVES

Two New Modalities Promising For Relapsed/Refractory NHL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Push to Get Exceptions, Adjustments For Clinical Research In DRG Regulations Gaining Momentum

July 22, 1983